Insight Molecular Diagnostics Inc. (IMDX) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$602
Total Return
-93.98%
CAGR
-43.00%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -2.33% |
| Median | -6.77% |
| Best | +113.29% |
| Worst | -57.57% |
| % of Windows Positive | 30.6% |
1-Year (252 Trading Days)
| Average | -21.41% |
| Median | -38.78% |
| Best | +268.66% |
| Worst | -88.66% |
| % of Windows Positive | 26.5% |
3-Year (756 Trading Days)
| Average | -69.89% |
| Median | -86.06% |
| Best | +42.43% |
| Worst | -97.65% |
| % of Windows Positive | 5.0% |
Risk Metrics
| Maximum Drawdown | -98.37% |
| Average Drawdown | -86.40% |
| Drawdown Duration | 1238 Trading Days (Unrecovered) |
| Sortino Ratio | -0.28 |
| Calmar Ratio | -0.44 |
| CVaR (5%) | -11.86% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -19.60% (-40.40% ann.) | $1960.10 | $0.00 | $0.00 | $0.00 |
| 2025 | +215.12% | +$21512.09 | $0.00 | $0.00 | $0.00 |
| 2024 | -4.80% | $479.64 | $0.00 | $0.00 | $0.00 |
| 2023 | -61.06% | $6106.02 | $0.00 | $0.00 | $0.00 |
| 2022 | -85.21% | $8520.73 | $0.00 | $0.00 | $0.00 |
| 2021 | -9.21% | $920.51 | $0.00 | $0.00 | $0.00 |
| 2020 | +6.22% | +$622.23 | $0.00 | $0.00 | $0.00 |
| 2019 | +63.04% | +$6304.34 | $0.00 | $0.00 | $0.00 |
| 2018 | -70.32% | $7032.26 | $0.00 | $0.00 | $0.00 |
| 2017 | -34.04% | $3404.26 | $0.00 | $0.00 | $0.00 |
| 2016 | +12.80% | +$1280.00 | $0.00 | $0.00 | $0.00 |
| 2015 partial | -22.65% (-100.00% ann.) | $2264.85 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | December 30, 2015 – February 19, 2020 | -67.57% | -23.82% | $6757.43 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -32.28% | -98.83% | $3228.09 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | -21.39% | -32.11% | $2139.27 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +52.63% | +49.36% | +$5263.16 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -73.33% | -75.42% | $7333.35 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -74.08% | -51.74% | $7408.33 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | +104.40% | +52.07% | +$10440.43 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.